Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Precision medicine in the management of type 2 diabetes.

The lancet. Diabetes & endocrinology - 1 Nov 2018

Gloyn Anna L, Drucker Daniel J

Abstract excerpt

The study of type 2 diabetes has been driven by advances in human genetics, epigenetics, biomarkers, mechanistic studies, and large clinical trials, enabling new insights into disease susceptibility, pathophysiology, progression, and development of complications. Simultaneously, several new drug classes with different mechanisms of action have been introduced over the past two decades, accompanied by data about...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to Diabetes Mellitus, Type 2
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypoglycemic Agents

Share to Pharmacogenetics

Share to Precision Medicine

Share to Treatment Outcome

Source

Identifiers

PMID: 29699867
DOI: 10.1016/S2213-8587(18)30052-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Precision medicine in the management of type 2 diabetes.PMID 29699867Read ↗

Precision medicine in type 2 diabetesSemantic proximity Read ↗

[A journey towards precision medicine in type 1 diabetes mellitus].Semantic proximity Read ↗

Precision medicine: The future in diabetes care?Semantic proximity Read ↗

Precision medicine in diabetes: an opportunity for clinical translation.Semantic proximity Read ↗

Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical PracticeSemantic proximity Read ↗

Precision diabetes: learning from monogenic diabetes.Semantic proximity Read ↗

Genetics of Type 2 Diabetes: Opportunities for Precision MedicineSemantic proximity Read ↗

Can genetics improve precision of therapy in diabetes?Semantic proximity Read ↗

The Need for Precision Medicine to be Applied to Diabetes.Semantic proximity Read ↗

Genomic medicine at the heart of diabetes management.Semantic proximity Read ↗

Current Progress in Pharmacogenetics of Second-Line Antidiabetic Medications: Towards Precision Medicine for Type 2 DiabetesSemantic proximity Read ↗

Personalized medicine in diabetes mellitus: current opportunities and future prospectsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.